| pubmed-article:19854630 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C0010674 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:19854630 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:19854630 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19854630 | pubmed:dateCreated | 2009-11-30 | lld:pubmed |
| pubmed-article:19854630 | pubmed:abstractText | In the past few years, survival has increased for people with cystic fibrosis (CF). Diabetes is an important complication of CF caused by pancreatic insufficiency, which reduces insulin secretion. Because of increased longevity of patients with CF, the prevalence of CF-related diabetes (CFRD) has increased. CFRD is associated with increased mortality and morbidity. Several studies have reported a decline in nutritional and pulmonary status 2-4 years before the diagnosis of CFRD. The introduction of insulin treatment can produce clinical improvement in weight and lung function. The oral glucose tolerance test is currently the reference method in screening for CFRD, but the current definition of diabetes based on the 2-h post-load plasma glucose level may not be the most accurate method for early detection of glucose tolerance abnormalities in CF. The continuous glucose monitoring system (CGMS) has been described as a useful tool for early detection of hyperglycemia in the CF patient. We tested the CGMS in CF patients with unexplained alteration of their general status. The aim of this study was to assess the value of the CGMS in this population. | lld:pubmed |
| pubmed-article:19854630 | pubmed:language | fre | lld:pubmed |
| pubmed-article:19854630 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19854630 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19854630 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19854630 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19854630 | pubmed:issn | 1769-664X | lld:pubmed |
| pubmed-article:19854630 | pubmed:author | pubmed-author:GrosuEE | lld:pubmed |
| pubmed-article:19854630 | pubmed:author | pubmed-author:ReynaudRR | lld:pubmed |
| pubmed-article:19854630 | pubmed:author | pubmed-author:SarlesJJ | lld:pubmed |
| pubmed-article:19854630 | pubmed:author | pubmed-author:StremlerNN | lld:pubmed |
| pubmed-article:19854630 | pubmed:author | pubmed-author:DubusJ-CJC | lld:pubmed |
| pubmed-article:19854630 | pubmed:author | pubmed-author:KhammarAA | lld:pubmed |
| pubmed-article:19854630 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19854630 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:19854630 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19854630 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19854630 | pubmed:pagination | 1540-6 | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:meshHeading | pubmed-meshheading:19854630... | lld:pubmed |
| pubmed-article:19854630 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19854630 | pubmed:articleTitle | [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis]. | lld:pubmed |
| pubmed-article:19854630 | pubmed:affiliation | Service de Pédiatrie Multidisciplinaire, Hôpital Timone-Enfants, 264 Rue Saint-Pierre, 13385 Marseille Cedex 05, France. khammar.assia@hotmail.fr | lld:pubmed |
| pubmed-article:19854630 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19854630 | pubmed:publicationType | English Abstract | lld:pubmed |
